Sernova to Present at H.C. Wainwright BioConnect 2021 Conference
December 18, 2020 - 9:00 a.m. EST
LONDON, ONTARIO – December 18, 2020 – Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, today announces that Dr. Philip Toleikis, President and CEO of Sernova will present at the H.C. Wainwright BioConnect 2021 Conference taking place virtually January 11-14.
Dr. Toleikis is scheduled to host a virtual presentation that will be available on demand during the conference, starting at 6:00 AM EST on Monday January 11, 2021. Sernova’s management team will also participate in one-on-one meetings at the conference.
H.C. Wainwright BioConnect 2021 Conference
Date: Monday, January 11, 2021 to Thursday, January 14, 2021
Time: On demand
Link: https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
For more information on the H.C. Wainwright BioConnect 2021 Conference or to schedule one-on-one meetings with management, please contact your H.C. Wainwright representative.
ABOUT SERNOVA CORP.
Sernova Corp is developing regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells (i.e. human donor cells, corrected human cells, and stem cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases such as insulin-dependent diabetes, blood disorders including hemophilia, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. For more information, please visit www.sernova.com
For further information contact:
Dominic Gray
Sernova Corp
Tel: (519) 858-5126
Sernova Corp. Stock
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Sernova Corp. stock is not clear.
Based on the current price of 0.19 € the target price of 12 € shows a potential of 6156.52% for Sernova Corp. which would more than double the current price.
